5 research outputs found

    Involvement of ionic channels and intracellular calcium on stimulatory effect of rT<sub>3</sub> on <sup>45</sup>Ca<sup>2+</sup> uptake.

    No full text
    <p>(A) Influence of flunarizine, (B) BAPTA-AM and (C) 9-AC on stimulatory effect of rT<sub>3</sub> on <sup>45</sup>Ca<sup>2+</sup> uptake in Sertoli cells. Pre-incubation: 15 min in KRb, additional pre-incubation: 60 min with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> and incubation time: 60 s with 0.1 µCi/mL of 45Ca2+ in the presence or absence of flunarizine (1 µM), BAPTA-AM (50 µM) and 9-AC (1 µM) with/without rT3 (10-17 M). Means ± S.E.M. For control, n=10; rT3, n=7; flunarizine, n=8; rT3 + flunarizine, n=8; BAPTA-AM, n=8; rT3 + BAPTA-AM, n=6; 9-AC, n=6; rT3 + 9-AC, n=6. ***P < 0.001 and **p < 0.01 compared with control group; ###p < 0.001; ##p < 0.01 and #p < 0.05 compared with rT3 group.</p

    Fluorescence images of Sertoli cells stained with quinacrine.

    No full text
    <p>Quinacrine stains individual secretory vesicles in the cell cytoplasm. Sertoli cells in culture were incubated with 3 µM quinacrine for 30 min, washed and photographed under fluorescence illumination immediately (A and C) and at 1 min intervals for 10 min of incubation in the absence or presence of rT<sub>3</sub>, respectively (B and D). Incubation of cells with 10<sup>-17</sup> M rT<sub>3</sub> caused fusion of quinacrine-loaded vesicles to the plasma membrane and release of the fluorescent content into the surrounding medium, as seen by the loss of fluorescence from most vesicles located at the cell periphery. This effect was observed after 4 min incubation with rT<sub>3</sub>. Also, Sertoli cells were incubated for 10 min with 500 nM of RGD peptide or 1 µM of flunarizine prior to incubation with quinacrine, washed and incubated with 3 µM quinacrine for 30 min. Quinacrine-loaded Sertoli cell cultures, pre-treated with RGD or flunarizine for 10 min, were incubated in the absence or presence of 10<sup>-17</sup> M rT<sub>3</sub> and photographed under fluorescence illumination immediately (E, G, I and K) and at 1-min intervals for 10 min of incubation in the absence or presence of rT<sub>3</sub> (F, H, J and L). Incubation of cells in the presence of 500 nM RGD peptide or 1 µM flunarizine prevented the fusion of quinacrine-loaded vesicles to the plasma membrane and release of the fluorescent content. (A) Control, 0 min. (B) Control, 4 min. (C) rT<sub>3</sub>, 0 min. (D) rT<sub>3</sub>, 4 min. (E) RGD, 0 min. (F) RGD, 4 min. (G) rT<sub>3</sub> + RGD, 0 min. (H) rT<sub>3</sub> + RGD, 4 min. (I) Flunarizine, 0 min. (F) Flunarizine, 4 min. (G) rT<sub>3</sub> + Flunarizine, 0 min. (H) rT<sub>3</sub> + Flunarizine, 4 min. Experiments were performed 3 times with similar results. Bar = 10 µm.</p

    Influence of RGD peptide on stimulatory effect of rT<sub>3</sub> on <sup>45</sup>Ca<sup>2+</sup> uptake in Sertoli cells.

    No full text
    <p>Pre-incubation: 15 min in KRb, additional pre-incubation: 60 min with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> and incubation time: 60 s with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> in the presence or absence of RGD peptide (5 x 10<sup>-7</sup> M) with/without rT<sub>3</sub> (10<sup>-17</sup> M). Means ± S.E.M. For control, rT<sub>3</sub>, RGD and rT3 + RGD, n=10 for each group. ***p < 0.001 compared with control group; ###<i>p</i> < 0.001 compared with rT<sub>3</sub> group.</p

    Involvement of kinases proteins on stimulatory effect of rT<sub>3</sub> on <sup>45</sup>Ca<sup>2+</sup> uptake in Sertoli cells.

    No full text
    <p>(A) Influence of stearoylcarnitine and (B) PD 98059. Pre-incubation: 15 min in KRb, additional pre-incubation: 60 min with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> and incubation time: 60 s with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> in the presence or absence of stearoylcarnitine (1 µM) and PD 98059 (30 µM) with/without rT<sub>3</sub> (10<sup>-17</sup> M). Means ± S.E.M. For control, n=9; rT<sub>3</sub>, n=6; stearoylcarnitine, n=8; rT<sub>3</sub> + stearoylcarnitine, n=9; PD 98059, n=8; rT<sub>3</sub> + PD 98059, n=8. ***<i>p</i> < 0.001 and *<i>p</i> < 0.05 compared with control group; ##<i>p</i> < 0.01 and #<i>p</i> < 0.05 compared with rT<sub>3</sub> group.</p

    Time-course and dose-response curve of rT<sub>3</sub> on Ca<sup>2+</sup> uptake in Sertoli cells.

    No full text
    <p>(A) Time-course effect of rT<sub>3</sub>. Pre-incubation: 15 min in KRb, additional pre-incubation: 60 min with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> and incubation time: 30, 60 and 300 s with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> in the presence or absence of rT<sub>3</sub> (10<sup>-17</sup> M). Means ± S.E.M. n= 4 for all groups. **<i>P</i> < 0.01 and *<i>p</i> < 0.05 compared with control group. (B) Dose-response curve for rT<sub>3</sub> in relation to Ca<sup>2+</sup> uptake in Sertoli cells. Pre-incubation: 15 min in KRb, additional pre-incubation: 60 min with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> and incubation time: 60 s with 0.1 µCi/mL of <sup>45</sup>Ca<sup>2+</sup> in the presence or absence of rT<sub>3</sub>. Means ± S.E.M. For control and rT<sub>3</sub> (10<sup>-19</sup>, 10<sup>-17</sup>, 10<sup>-15</sup>, 10<sup>-13</sup>, 10<sup>-11</sup>, 10<sup>-9</sup> and 10<sup>-7</sup> M), n=4 for each group. **<i>P</i> < 0.01 and *<i>p</i> < 0.05 compared with control group. </p
    corecore